These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
582 related articles for article (PubMed ID: 25609943)
1. Managing comorbidities in COPD. Hillas G; Perlikos F; Tsiligianni I; Tzanakis N Int J Chron Obstruct Pulmon Dis; 2015; 10():95-109. PubMed ID: 25609943 [TBL] [Abstract][Full Text] [Related]
2. Impact of Comorbidities on the Treatment of Chronic Obstructive Pulmonary Disease. Garvey C; Criner GJ Am J Med; 2018 Sep; 131(9S):23-29. PubMed ID: 29777661 [TBL] [Abstract][Full Text] [Related]
3. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review. Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831 [TBL] [Abstract][Full Text] [Related]
6. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol. Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110 [TBL] [Abstract][Full Text] [Related]
7. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention. Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149 [TBL] [Abstract][Full Text] [Related]
8. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880 [TBL] [Abstract][Full Text] [Related]
9. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440 [TBL] [Abstract][Full Text] [Related]
10. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Morgan AD; Zakeri R; Quint JK Ther Adv Respir Dis; 2018; 12():1753465817750524. PubMed ID: 29355081 [TBL] [Abstract][Full Text] [Related]
11. Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease. Rogliani P; Brusasco V; Fabbri L; Ungar A; Muscianisi E; Barisone I; Corsini A; De Angelis G Expert Rev Respir Med; 2018 Feb; 12(2):103-112. PubMed ID: 29241393 [TBL] [Abstract][Full Text] [Related]
12. COPD and associated comorbidities: a review of current diagnosis and treatment. Carlin BW Postgrad Med; 2012 Jul; 124(4):225-40. PubMed ID: 22913911 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a simple intervention on management of acute exacerbations of chronic obstructive pulmonary disease and its cardiovascular comorbidities: COREPOC study. Díez-Manglano J; Recio Iglesias J; Varela Aguilar JM; Almagro Mena P; Zubillaga Garmendia G; Med Clin (Barc); 2017 Sep; 149(6):240-247. PubMed ID: 28396131 [TBL] [Abstract][Full Text] [Related]
14. Improving outcomes in chronic obstructive pulmonary disease: the role of the interprofessional approach. Amalakuhan B; Adams SG Int J Chron Obstruct Pulmon Dis; 2015; 10():1225-32. PubMed ID: 26170651 [TBL] [Abstract][Full Text] [Related]
15. Guideline for the management of chronic obstructive pulmonary disease--2011 update. Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M; S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617 [TBL] [Abstract][Full Text] [Related]
16. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study]. Jahnz-Rózyk K; Targowski T; From S Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534 [TBL] [Abstract][Full Text] [Related]
17. Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. Panagioti M; Scott C; Blakemore A; Coventry PA Int J Chron Obstruct Pulmon Dis; 2014; 9():1289-306. PubMed ID: 25419126 [TBL] [Abstract][Full Text] [Related]
18. Coexisting chronic obstructive pulmonary disease and cardiovascular disease in clinical practice: a diagnostic and therapeutic challenge. Leong P; Macdonald MI; Ko BS; Bardin PG Med J Aust; 2019 May; 210(9):417-423. PubMed ID: 30907000 [TBL] [Abstract][Full Text] [Related]
19. [Comorbidities and psoriasis. Impact on clinical practice]. Gerdes S; Mrowietz U Hautarzt; 2012 Mar; 63(3):202-13. PubMed ID: 22373901 [TBL] [Abstract][Full Text] [Related]
20. Implementation challenges in delivering team-based care ('TEAMcare') for patients with chronic obstructive pulmonary disease in a public hospital setting: a mixed methods approach. Cochrane B; Foster J; Boyd R; Atlantis E BMC Health Serv Res; 2016 Aug; 16(a):347. PubMed ID: 27488412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]